Skip to main content

Table 2 Five-year incidence of dyslipidaemia (Page 7)

From: Risk prediction model of dyslipidaemia over a 5-year period based on the Taiwan MJ health check-up longitudinal database

  Number(all) Percentage within all (%) Percentage within dyslipidaemia (%) Percentage within item (%)
Developed into dyslipidaemia 1170 19.39   
 1 item 819 13.58 70.00  
  HDL-C 515 8.54 44.02 62.88
  TC 135 2.24 11.54 16.48
  TG 123 2.04 10.51 15.02
  LDL-C 46 0.76 3.93 5.62
 2 item 290 4.81 24.79  
  LDL-C & TC 167 2.77 14.27 57.59
  HDL-C & TG 80 1.33 6.84 27.59
  TG & TC 24 0.40 2.05 8.28
  LDL-C & HDL-C 18 0.30 1.54 6.21
  HDL-C & TC 1 0.02 0.09 0.34
  LDL-C & TG 0 0.00 0.00 0.00
 3 item 23 0.38 1.97  
  LDL-C & TG &TC 10 0.17 0.85 43.48
  LDL-C & HDL-C & TC 9 0.15 0.77 39.13
  TC & HDL-C & TG 4 0.07 0.34 17.39
  LDL-C & HDL-C & TG 0 0.00 0.00 0.00
 4 item 2 0.03 0.17  
  TC & LDL-C & HDL-C& TG 2 0.03 0.17  
Lipid-lowering medication 36 0.60 3.08  
Remaining normal 4863 80.61   
  1. Note: The incidence of dyslipidaemia in the table is the crude incidence e and does not standardize by age and sex